Pharma Firms Boost Consumer Drug Ads Amid Tax Benefits Concerns

Brand pharmaceutical companies significantly increased their consumer-targeted advertising spending in early 2025, with the top 10 advertisers boosting their TV commercial budgets by almost 30% year-over-year.

This heightened marketing effort spans various media platforms, including TV, print, digital, and outdoor advertising, aiming to drive demand for high-cost brand-name prescription drugs. Concurrently, these companies benefit from substantial tax deductions related to their marketing expenditures, which has raised concerns regarding the impact of such practices on prescription drug pricing in the U.S.